CD8A and post-transplant lymphoproliferative disease: Nevertheless, successful adoptive transfer experiments of EBV-specific CD8+ T cells in lymphoma and PTLD patients, and depletion experiments in humanized mice leading to increased lymphomagenesis underline the protective value of EBV-specific CD8+ T cells [166,167].